R Sealy, P Helman. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useHeadHead and Neck Neoplasms/drug therapyHead and Neck Neoplasms/radiotherapyHead and Neck Neoplasms/therapyHumansInjections, Intra-ArterialMethotrexate/administration & dosageMethotrexate/adverse effectsMethotrexate/therapeutic useNeoplasms/drug therapyNeoplasms/radiotherapyNeoplasms/therapyThiotepa/administration & dosageThiotepa/therapeutic useTime FactorsVinblastine/administration & dosageVinblastine/adverse effectsVinblastine/therapeutic use
Substances： See more » Antineoplastic AgentsVinblastineThiotepaMethotrexate
Year: 1972 PMID： 4625192 DOI： 10.1002/1097-0142(197207)30:1<187::aid-cncr2820300126>3.0.co;2-0
Source DB: PubMed Journal: Cancer ISSN： 0008-543X Impact factor: 6.860